1 – 10 of 34
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Molecular stratification of metastatic melanoma using gene expression profiling: prediction of survival outcome and benefit from molecular targeted therapy.
(
- Contribution to journal › Article
-
Mark
Nonsense Mutations in the Shelterin Complex Genes ACD and TERF2IP in Familial Melanoma.
(
- Contribution to journal › Article
- 2014
-
Mark
High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer.
(
- Contribution to journal › Article
- 2008
-
Mark
Confirmed cancer trends in families of patients with multiple cancers including cutaneous melanoma.
(
- Contribution to journal › Article
- 2007
-
Mark
Absence of the common IGF1 19 CA-repeat allele is more common among BRCA1 mutation carriers than among non-carriers from BRCA1 families.
(
- Contribution to journal › Article
- 2006
-
Mark
Differences in IGFBP-3 regulation between young healthy women from BRCAX families and those belonging to BRCA1/2 families.
(
- Contribution to journal › Article
- 2005
-
Mark
High follicular phase luteinizing hormone levels in young healthy BRCA1 mutation carriers: Implications for breast and ovarian cancer risk.
(
- Contribution to journal › Article
-
Mark
Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
(
- Contribution to journal › Article
- 2004
-
Mark
Melanoma and nonmelanoma skin cancer in patients with multiple tumours-evidence for new syndromes in a population-based study.
(
- Contribution to journal › Article
-
Mark
One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations : results of a prospective study in Southern Sweden
(
- Contribution to journal › Article